Iodomarin 200 tablets 200mcg №25×4

Name:
Iodomarin 200 tab. 200mcg in a blister. in pack. No. 25×4
Description:
Tablets of white or almost white color, round, flat-cylindrical, with a chamfer and a notch on one side. The main active ingredient Iodine Release form Tablets of white or almost white color, round, flat-cylindrical, with a chamfer and a risk on one side. 1 tab. potassium iodide 262 mcg, which corresponds to an iodine content of 200 mcg stearate – 2 mg. 25 pcs. – blisters (2) – packs of cardboard. 25 pcs. – blisters (4) – packs of cardboard. Special instructions Effect on the ability to drive vehicles and control mechanisms Iodomarin® does not affect the ability to drive vehicles and other potentially hazardous activities. Pharmacological actionIodine preparation for the treatment and prevention of thyroid diseases. Iodine is a vital trace element necessary for the normal functioning of the thyroid gland. Thyroid hormones perform many vital functions, incl. regulate the metabolism of proteins, fats, carbohydrates and energy in the body, the activity of the brain, nervous and cardiovascular systems, sex and mammary glands, as well as the growth and development of the child. The use of the drug Iodomarin® replenishes iodine deficiency in the body, preventing the development of iodine deficiency diseases, contributes to the normalization of thyroid function, which is especially important for children and adolescents, as well as during pregnancy and lactation. Pharmacokinetics Data on the pharmacokinetics of the drug Iodomarin® are not available. Indications for use – prevention of endemic goiter (especially in children, adolescents, women during pregnancy and during breastfeeding); – prevention of recurrence of goiter after its surgical removal or after the end of drug treatment with thyroid hormone preparations; – treatment of diffuse euthyroid goiter caused by iodine deficiency in children, adolescents and adults under the age of 40 years. Dosage and administration Prevention of endemic goiter Newborns and children under the age of 12 years 1/2-1 tab. drug Iodomarin® 100 or 1/2 tab. drug Iodomarin® 200 per day (which corresponds to 50-100 mcg of iodine). Children over 12 years old and adults 1-2 tab. drug Iodomarin® 100 or 1/2-1 tab. drug Iodomarin® 200 per day (which corresponds to 100-200 mcg of iodine). During pregnancy and lactation 2 tab. drug Iodomarin® 100 or 1 tab. drug Iodomarin® 200 per day (which corresponds to 200 mcg of iodine). Prevention of recurrence of goiter 1-2 tab. drug Iodomarin® 100 or 1/2-1 tab. drug Iodomarin® 200 per day (which corresponds to 100-200 mcg of iodine). Treatment of euthyroid goiter Newborns and children aged 1 to 18 years 1-2 tab. drug Iodomarin® 100 or 1/2-1 tab. drug Iodomarin® 200 per day (which corresponds to 100-200 mcg of iodine). Adults up to 40 years 3-5 tab. drug Iodomarin® 100 per day or 11/2-21/2 tab. drug Iodomarin® 200 per day (which corresponds to 300-500 mcg of iodine). The drug is taken after meals with a sufficient amount of liquid. When used in children, it is recommended to pre-dissolve the drug in milk or juice. Preventive reception is carried out for several years, if there are indications – for life. For the treatment of goiter in newborns, on average, 2-4 weeks are enough; in children, adolescents and adults, it usually takes 6-12 months, long-term use is possible. The duration of treatment is determined by the attending physician. Application during pregnancy and lactation During pregnancy and lactation, the need for iodine increases, so it is especially important to use the drug Iodomarin® in sufficient doses (200 mcg / day) to ensure adequate intake of iodine in the body. The use of the drug Iodomarin® during pregnancy and lactation (breastfeeding) is possible only in recommended doses, because. the active substance crosses the placenta and is excreted in breast milk. Precautions May be used in children according to indications. Interaction with other drugs Iodine deficiency increases, and excess iodine reduces the effectiveness of hyperthyroidism therapy with thyreostatic agents (before or during the treatment of hyperthyroidism it is recommended, if possible, to avoid any use of iodine). On the other hand, thyreostatic agents inhibit the conversion of iodine into an organic compound in the thyroid gland and thus can cause goiter formation. Simultaneous treatment with high doses of iodine and lithium salt preparations can contribute to the onset of goiter and hypothyroidism. High doses of the drug in combination with potassium-sparing diuretics can lead to hyperkalemia. Contraindications – hyperthyroidism; – toxic adenoma of the thyroid gland, nodular goiter when used in doses of more than 300 mcg / day (with the exception of the period of preoperative iodine therapy to block the function of the thyroid gland); – herpetiform (senile) Dühring’s dermatitis; – Hypersensitivity to iodine. The drug should not be used in hypothyroidism, except in cases where the development of the latter is caused by severe iodine deficiency. Prescribing the drug should be avoided during therapy with radioactive iodine, the presence or suspicion of thyroid cancer. Ingredients: Potassium iodide 262 mcg, which corresponds to an iodine content of 200 mcg stearate – 2 mg. OverdoseSymptoms: staining of the mucous membranes in brown, reflex vomiting (if there are starch-containing components in the food, the vomit becomes blue), abdominal pain and diarrhea (possibly melena). In severe cases, dehydration and shock may develop. In rare cases, stenosis of the esophagus, the phenomenon of “iodism” was observed. Treatment: in case of acute intoxication – withdrawal of the drug, gastric lavage with a solution of starch, protein or 5% sodium thiosulfate solution until all traces of iodine are removed; with chronic intoxication – drug withdrawal. Symptomatic therapy of water balance disorders, electrolyte balance, antishock therapy. In the treatment of iodine-induced hypothyroidism – the abolition of the drug, the normalization of metabolism with the help of thyroid hormones. In the treatment of iodine-induced thyrotoxicosis – with mild forms of treatment is not required, with severe forms thyrostatic therapy is required (the effect of which is always delayed). In the most severe cases (thyrotoxic crisis), intensive care, plasmapheresis or thyroidectomy is necessary. Side effects With the prophylactic use of the drug Iodomarin® in patients of any age, side effects, as a rule, are not observed. On the part of the endocrine system: when using the drug at a dose of more than 150 mcg of iodine / day, latent hyperthyroidism can turn into a manifest form; when using the drug at a dose exceeding 300 mcg of iodine / day, iodine-induced thyrotoxicosis may develop (especially in elderly patients suffering from goiter for a long time, in the presence of nodular goiter or diffuse toxic goiter). Allergic reactions: rarely – iodism, manifested by a metallic taste in the mouth, swelling and inflammation of the mucous membranes (“iodine” rhinitis, conjunctivitis, bronchitis), “iodine” fever, “iodine” acne; in some cases – Quincke’s edema, exfoliative dermatitis. Storage conditions The drug should be stored out of the reach of children, dry, dark place at a temperature not exceeding 25°C. Buy Iodomarin 200 tablets 200mcg No. 25×4 Price for Iodomarin 200 tablets 200mcg No. 25×4